About Index Trending news
Analyze
Pricing
Promentis Pharmaceuticals

Promentis Pharmaceuticals

Work at Promentis Pharmaceuticals? Add yourself to this profile

Promentis Pharmaceuticals

Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Alimera Sciences Alimera Sciences Sirenas Marine Discovery Sirenas Marine Discovery Ritter Pharmaceuticals, Inc. Ritter Pharmaceuticals, Inc. Napo Pharmaceuticals Napo Pharmaceuticals Prospective Research Prospective Research Prexton Therapeutics SA Prexton Therapeutics SA Clontech Laboratories Inc Clontech Laboratories Inc Esperion Therapeutics Esperion Therapeutics AFFiRiS AG AFFiRiS AG XOR Labs Toronto XOR Labs Toronto

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital (Series C)
$26,000,000
Aisling Capital, OrbiMed, F-Prime Capital Partners
Venture capital
$8,700,000
Employees

Team size

10+
Locations
HQ
United States
Headquarters
$26,000,000 Venture capital (Series C)
Xconomy

Promentis Pharmaceuticals Completes $26M Financing to Advance CNS Drug

Funding Science
Promentis Pharmaceuticals
Promentis Pharmaceuticals
PE Hub

Promentis Pharmaceuticals pulls in $26 mln Series C

Funding Messaging
Promentis Pharmaceuticals
Promentis Pharmaceuticals
$8,700,000 Venture capital
Milwaukee Journal Sentinel

Promentis raises $8.7 million

Promentis Pharmaceuticals
Promentis Pharmaceuticals